COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Price, Quote, News and Overview

What is the stock price of COLLPLANT BIOTECHNOLOGIES LT today?

The current stock price of CLGN is 1.82 USD. The price decreased by -2.15% in the last trading session.

What is the ticker symbol for COLLPLANT BIOTECHNOLOGIES LT stock?

The exchange symbol of COLLPLANT BIOTECHNOLOGIES LT is CLGN and it is listed on the Nasdaq exchange.

On which exchange is CLGN stock listed?

CLGN stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for COLLPLANT BIOTECHNOLOGIES LT stock?

7 analysts have analysed CLGN and the average price target is 14.28 USD. This implies a price increase of 684.62% is expected in the next year compared to the current price of 1.82. Check the COLLPLANT BIOTECHNOLOGIES LT stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is COLLPLANT BIOTECHNOLOGIES LT worth?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) has a market capitalization of 20.84M USD. This makes CLGN a Nano Cap stock.

How many employees does COLLPLANT BIOTECHNOLOGIES LT have?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) currently has 57 employees.

What are the support and resistance levels for COLLPLANT BIOTECHNOLOGIES LT (CLGN) stock?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) has a resistance level at 3.57. Check the full technical report for a detailed analysis of CLGN support and resistance levels.

Is COLLPLANT BIOTECHNOLOGIES LT (CLGN) expected to grow?

The Revenue of COLLPLANT BIOTECHNOLOGIES LT (CLGN) is expected to grow by 601.14% in the next year. Check the estimates tab for more information on the CLGN EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy COLLPLANT BIOTECHNOLOGIES LT (CLGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CLGN, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CLGN, evaluating the profitability, health, valuation and growth aspects
• COLLPLANT BIOTECHNOLOGIES LT (CLGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• COLLPLANT BIOTECHNOLOGIES LT (CLGN) Sales and EPS estimates to see what analysts future expectations are.
• COLLPLANT BIOTECHNOLOGIES LT (CLGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• COLLPLANT BIOTECHNOLOGIES LT (CLGN) Insider and Institutional Ownership to learn about the owners and their transactions.
• COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Chart to make your own analysis
• COLLPLANT BIOTECHNOLOGIES LT (CLGN) Latest news and press-releases to stay up to date.

Does COLLPLANT BIOTECHNOLOGIES LT (CLGN) stock pay dividends?

CLGN does not pay a dividend.

When does COLLPLANT BIOTECHNOLOGIES LT (CLGN) report earnings?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) will report earnings on 2025-05-22.

What is the Price/Earnings (PE) ratio of COLLPLANT BIOTECHNOLOGIES LT (CLGN)?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.46).

What is the Short Interest ratio of COLLPLANT BIOTECHNOLOGIES LT (CLGN) stock?

The outstanding short interest for COLLPLANT BIOTECHNOLOGIES LT (CLGN) is 0.03% of its float. Check the ownership tab for more information on the CLGN short interest.

ChartMill assigns a fundamental rating of 3 / 10 to CLGN. CLGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.

Over the last trailing twelve months CLGN reported a non-GAAP Earnings per Share(EPS) of -1.46. The EPS decreased by -217.39% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to CLGN. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 92.32% and a revenue growth 601.14% for CLGN